Claritas Pharmaceuticals, Inc. (CLAZF)
OTCMKTS · Delayed Price · Currency is USD
0.0000
0.00 (0.00%)
At close: May 19, 2025
Claritas Pharmaceuticals Market Cap
Claritas Pharmaceuticals has a market cap or net worth of $38.00 as of August 1, 2025. Its market cap has decreased by -100.00% in one year.
Market Cap
38.00
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
0.00
Stock Price
$0.00
Market Cap Chart
Since January 11, 2017, Claritas Pharmaceuticals's market cap has decreased from 56.78M to 38.00, a decrease of -100.00%. That is a compound annual growth rate of -81.76%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 19, 2025 | 38.00 | - |
| Dec 24, 2024 | 38.00 | -98.66% |
| Dec 28, 2023 | 2.83K | -99.25% |
| Dec 30, 2022 | 377.87K | -92.96% |
| Dec 31, 2021 | 5.37M | -72.06% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Jan 11, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Endo, Inc. | 1.76B |
| Veradigm | 794.80M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 546.09M |
| Glass House Brands | 409.73M |
| Nika Pharmaceuticals | 366.89M |
| CytoDyn | 357.98M |
| Northwest Biotherapeutics | 351.67M |